Two newly approved oral treatments for Covid-19 are recommended mainly for unvaccinated patients and will not be available for Australia’s general practitioners to prescribe for “many, many weeks”.
The antiviral drugs Lagevrio and Paxlovid block the ability of the Sars-CoV-2 virus to replicate in the body, and were provisionally approved by the Therapeutic Goods Administration on 20 January.